Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience

Antonella Brunello,Mario Domenico Rizzato,Marco Rastrelli,Anna Roma,Marco Maruzzo,Umberto Basso,Pasquale Fiduccia,M. S. Buzzaccarini,Giovanni Scarzello,Carlo Riccardo Rossi,Vittorina Zagonel

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience

2016

Antonella Brunello
Mario Domenico Rizzato
Marco Rastrelli
Anna Roma
Marco Maruzzo
Umberto Basso
Pasquale Fiduccia
M. S. Buzzaccarini
Giovanni Scarzello
Carlo Riccardo Rossi
Vittorina Zagonel

Purpose The role of adjuvant chemotherapy (ACT) for soft tissue sarcomas (STS) is not standard practice. We investigated effectiveness and tolerability of ACT in patients (pts) with operated high-risk STS in clinical practice.

Keywords:

Ifosfamide
Adjuvant
Soft Tissue Neoplasm
Pathology
Soft tissue
Sarcoma
Epirubicin
Oncology
Internal medicine
Medicine
Tolerability
Chemotherapy
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations